KZA 0.00% $1.53 kazia therapeutics limited

*** something very interesting ***

  1. 3,567 Posts.
    A US company called Genentech (DNA) released today a statement saying their cancer drug for Colon cancer has improved survival. The rumor I heard was 6 months. This is no cure but it still a better result than current treatments.

    Genentech are also presenting at ASCO with detailed numbers.

    Here is the interesting part. Guess how much Genentech went up today in what was a very much down market for the Nasdaq and Pharma's???

    Genentech went up USD8.5bn (in market cap)!!! Yes you read correctly!!! For Novogen (NRT) that would equate to $136 per share.

    And the great part about it is that Novogen's Phenoxodiol is active against over 70 different types of cancer (in-vitro). We already know that Yale has seen positive Phase II results to some degree (Dr Rutherfords comments) but the investment community still hasn't caught on... especially here on the ASX.

    With the big ASCO presentation only two weeks away I think I'll have to increase my share price target to well over $10 in the short term.

    Cheers to all NRT longs,

watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Mkt cap ! $193.6M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
5 13519 $1.55

Sellers (Offers)

Price($) Vol. No.
$1.65 5717 1
View Market Depth
Last trade - 16.16pm 16/04/2021 (20 minute delay) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.